ASCO 2016 | Targeted therapy for advanced solid tumors based on molecular profiles: early results from MyPathway

John Hainsworth

Press brief by John Hainsworth, MD of the Sarah Cannon Research Institute, Nashville, TN, at the 2016 Annual Meeting of the American Society of Clinical Oncology (ASCO), held in Chicago, IL.

Share this video  
Similar topics
Related videos
3:05
Producing patient-specific tumor-reactive T-cells
Chiara Cattaneo
0:58
TNBC treatment: platinum-based therapy and PARP inhibition
Véronique Dieras
2:59
BROCADE3: veliparib with carboplatin/paclitaxel in HER2-/BRCA+ advanced breast cancer
Véronique Dieras
1:27
Health-related QoL in ipilimumab treated advanced melanoma survivors
Christian Blank
1:34
OpACIN and OpACIN-neo trial updates
Christian Blank
Breast Cancer, Lung Cancer, Skin Cancer
ASCO 2016
Press Brief
3rd June 2016
vjoncology logo VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

VJO needs the contact information you provide to inform you about our latest oncology news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

The content of VJOncology is intended for healthcare professionals